Black patients more likely to be excluded from prostate cancer trials

A recent issue explaining how indiscriminate tracking of certain markers (serum creatine, neutrophil count) can lead (here in the case of prostate cancer) to erroneously exclude healthy people subject to naturally higher rates of these markers.

Leave a Reply

Your email address will not be published. Required fields are marked *